A detailed history of Smithfield Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Smithfield Trust CO holds 3,668 shares of AMGN stock, worth $1.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,668
Previous 3,438 6.69%
Holding current value
$1.03 Million
Previous $1.07 Million 9.92%
% of portfolio
0.06%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $71,157 - $77,597
230 Added 6.69%
3,668 $1.18 Million
Q4 2023

Feb 07, 2024

SELL
$255.7 - $288.46 $11,250 - $12,692
-44 Reduced 1.26%
3,438 $983,000
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $19,927 - $23,563
-93 Reduced 2.6%
3,482 $771,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $25,740 - $31,372
114 Added 3.29%
3,575 $860,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $11,451 - $14,550
-50 Reduced 1.42%
3,461 $908,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $8,529 - $9,619
38 Added 1.09%
3,511 $790,000
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $34,606 - $38,511
-150 Reduced 4.14%
3,473 $844,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $16,308 - $18,663
-82 Reduced 2.21%
3,623 $812,000
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $21,227 - $24,870
100 Added 2.77%
3,705 $789,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $120,940 - $140,937
-545 Reduced 13.13%
3,605 $896,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $25,316 - $30,147
117 Added 2.9%
4,150 $954,000
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $10,324 - $11,481
44 Added 1.1%
4,033 $1.03 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $94,553 - $116,029
478 Added 13.61%
3,989 $941,000
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $22,233 - $29,487
-122 Reduced 3.36%
3,511 $712,000
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $1,702 - $2,188
-9 Reduced 0.25%
3,633 $876,000
Q3 2019

Oct 30, 2019

BUY
$174.11 - $208.62 $17,411 - $20,862
100 Added 2.82%
3,642 $705,000
Q2 2019

Aug 06, 2019

BUY
$166.7 - $195.41 $16,836 - $19,736
101 Added 2.94%
3,542 $653,000
Q1 2019

Apr 30, 2019

SELL
$180.87 - $203.88 $72,167 - $81,348
-399 Reduced 10.39%
3,441 $654,000
Q4 2018

Feb 04, 2019

BUY
$178.4 - $208.25 $68,148 - $79,551
382 Added 11.05%
3,840 $748,000
Q3 2018

Nov 05, 2018

BUY
$185.29 - $208.89 $11,673 - $13,160
63 Added 1.86%
3,458 $717,000
Q2 2018

Jul 16, 2018

SELL
$166.05 - $186.51 $34,870 - $39,167
-210 Reduced 5.83%
3,395 $627,000
Q1 2018

May 10, 2018

SELL
$169.43 - $198.0 $49,134 - $57,420
-290 Reduced 7.45%
3,605 $614,000
Q4 2017

Feb 02, 2018

SELL
$168.79 - $188.59 $7,257 - $8,109
-43 Reduced 1.09%
3,895 $678,000
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $658,788 - $752,158
3,938
3,938 $734,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.